Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany Retrospective Analysis of a Large Prescription Database-论文-万方医学网

Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany Retrospective Analysis of a Large Prescription Database

导出原文传递

翻译打印收藏纠错

作者： Helwig, Ulf ^[1] ; Kostev, Karel ^[2] ; Schmidt, Carsten ^[3]

作者单位： Practice Internal Med, Oldenburg, Germany ^[1] IQVIA, Dept Epidemiol, Unterschweinstiege 2-14, D-60549 Frankfurt, Germany ^[2] Klinikum Fulda, Med Clin 2, Dept Gastroenterol Hepatol Endocrinol Diabetol &, Fulda, Germany ^[3]

关键词 inflammatory bowel disease persistence vedolizumab biological retrospective analysis

发布时间 2021-03-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany Retrospective Analysis of a Large Prescription Database

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany Retrospective Analysis of a Large Prescription Database

相似文献

相关期刊

检索历史清除